20 Cities with the Cheapest Weed in the World

In This Article:

In this article, we are going to discuss the 20 cities with the cheapest weed in the world. You can skip our detailed analysis of the place with the most expensive weed in the world, the global cannabis industry, the budding cannabis-based pharmaceutical industry and the interest of big pharma, and the rise of e-commerce in the cannabis industry, and go directly to 5 Cities with the Cheapest Weed in the World

Before the war on drugs put marijuana farmers firmly in its crosshairs, cannabis was being grown openly and with commercial success on every continent on earth, much as it had been for centuries. However, with the passage of time, marijuana came to be perceived as a threat to the order of society, and stamping it out naturally began with laws on prohibition. 

Most Expensive Weed in the World: 

Before we step into the realm of cheap ganja, let’s talk about the place where indulging in marijuana will put a serious dent in your wallet. According to Price of Weed – a website that uses self-reporting to aggregate prices in various countries – Bermuda is the place with the most expensive weed in the world, where a gram of the herb will set you back by over $50. 

Global Cannabis Industry: 

As we mentioned in our article – 20 Cities with the Highest Weed Consumption in the World– the global cannabis market was valued at $47.32 billion in 2022, and is projected to grow from $57.18 billion in 2023 to $444.34 billion by 2030, growing at a CAGR of 34% during the forecast period. 

North America dominates the market and is projected to be the fastest growing region. Marijuana legalization is gaining momentum around the globe, driven primarily by the increasing recognition that the product may have a range of legitimate medicinal benefits and therapeutic applications. It is the most widely cultivated, trafficked, and consumed drug worldwide. 

Cannabis-based Pharmaceutical Industry: 

The FDA understands that there is increasing interest in the potential utility of cannabis for a variety of medical conditions. In 2018, the federal watchdog approved the country’s first-ever drug derived from marijuana – Epidiolex. Produced by GW Pharmaceuticals, the drug is used to treat two rare forms of epilepsy. 

The $7.2 billion acquisition of GW Pharmaceuticals by the global biopharma giant Jazz Pharmaceuticals plc (NASDAQ:JAZZ) in 2021 is the latest sign of the growing legitimacy and increased receptivity of cannabis-based drugs in the pharma industry. With the new purchase, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) – which has focused primarily on sleep medications and oncology – has augmented its neuroscience portfolio. Net product sales of Epidiolex reached $746.4 million in 2022 – an increase of 12% from the previous year – according to an announcement by Jazz Pharmaceuticals plc (NASDAQ:JAZZ).